Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,977 | -178,297 | -140,801 | -93,113 | -45,939 |
| Depreciation Amortization | 5,102 | 20,482 | 15,173 | 9,920 | 4,722 |
| Accounts receivable | -932 | -103 | -2,328 | -1,430 | -1,522 |
| Other Working Capital | -27,791 | -101,895 | -79,741 | -54,913 | -34,884 |
| Other Operating Activity | 8,623 | 26,562 | 27,160 | 18,419 | 9,073 |
| Operating Cash Flow | $-58,975 | $-233,251 | $-180,537 | $-121,117 | $-68,550 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,544 | 271,596 | 216,103 | 149,920 | 53,304 |
| PPE Investments | -2,839 | -23,278 | -20,420 | -15,213 | -7,950 |
| Purchase Of Investment | N/A | -119 | -119 | -119 | -65 |
| Investing Cash Flow | $1,705 | $248,199 | $195,564 | $134,588 | $45,289 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 74 | 36,116 | 33,734 | 27,979 | 17,469 |
| Other Financing Activity | -1,641 | -3,258 | -2,988 | -2,725 | -2,234 |
| Financing Cash Flow | $-1,567 | $32,858 | $30,746 | $25,254 | $15,235 |
| Exchange Rate Effect | 222 | -263 | -148 | -176 | -328 |
| Beginning Cash Position | 180,372 | 132,829 | 132,829 | 132,829 | 132,829 |
| End Cash Position | 121,757 | 180,372 | 178,454 | 171,378 | 124,475 |
| Net Cash Flow | $-58,615 | $47,543 | $45,625 | $38,549 | $-8,354 |
| Free Cash Flow | |||||
| Operating Cash Flow | -58,975 | -233,251 | -180,537 | -121,117 | -68,550 |
| Capital Expenditure | -2,839 | -23,278 | -20,420 | -15,213 | -7,950 |
| Free Cash Flow | -61,814 | -256,529 | -200,957 | -136,330 | -76,500 |